Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 USD | +2.78% | +10.30% | +657.91% |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+657.91% | 222M | |
+8.92% | 114B | |
+10.48% | 105B | |
-3.44% | 21.73B | |
-6.45% | 23.83B | |
-10.70% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Elevation Oncology Expands Phase 1 Study of Potential Solid Tumor Treatment